RecoSMA: Innovative Laser Therapy for Chronic Wound Treatment and Prevention - New Clinical Publication!

We're proud to share the results of a significant clinical trial published in the International Wound Journal, demonstrating the superior effectiveness of Erbium:YAG laser therapy with our patented RecoSMA technology in treating chronic lower extremity ulcers.

Key findings: 

• More than twice the rate of complete wound healing compared to traditional sharp debridement (56% vs. 26%)
• Faster clearance of microbial flora and wound detritus
• Rapid tissue regeneration, earlier granulation, and improved epithelialisation
• Significant reduction in patient-reported pain and improved comfort

This groundbreaking study further confirms Er:YAG laser with RecoSMA as a powerful tool in wound care, revolutionizing how chronic ulcers can be treated efficiently and painlessly.

Explore the full study here: https://lnkd.in/enyiCtaP